No, The FDA has warned about unapproved GLP-1 products (including semaglutide and tirzepatide) sold online and mislabeled for research purposes or not for human consumption, with unknown quality and potential harm
[10] Research suggests this selectivity profile might distinguish Ipamorelin from earlier GHS-R1a agonists such as GHRP-6 and GHRP-2, which are associated with ACTH and cortisol co-elevation, and may support its relevance as a precision tool for investigating GH axis modulation without concurrent hypothalamic-pituitary-adrenal axis perturbation
4.4 Maternal RPM supplementation and offspring performance Considering that embryonic development is the period of extensive epigenetic reprogramming, maternal nutrition during the periconceptional and early pregnancy stages plays a crucial role in establishing the molecular and physiological foundations for fetal growth and long-term offspring performance
While the overall risk appears to be small, I now screen more carefully for patients with risk factors such as pre-existing optic nerve problems, glaucoma, or significant diabetic retinopathy. Recent research also connects liraglutide, the active ingredient in Saxenda and Victoza, to similar concerns
Competitive Landscape : If approved, CT-388 would likely join other GLP-1 receptor agonists and various combination therapies on the market